China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...

China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...

In Ireland, WuXi Biologics has sold a new vaccines plant to Merck & Co. for €500 million ($521 million). The New Jersey ...

WuXi Biologics sells its vaccine production facility in Ireland to Merck & Co for $500m in the wake of changing regulation in ...

China's WuXi Biologics has confirmed it will sell its vaccine facility in Ireland to US drugmaker Merck & Co for about €500 ...

Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at ...

The startup is developing a kind of macrocyles, which share strengths of both small molecules and biologics, as oral ...

A new, two-step strategy for making substituted piperidines offers chemists a more efficient way to make these biologically ...

With cases of Feline Infectious Peritonitis (FIP) on rise in China, cat owners are making their pets pop in Covid-19 drugs as antidotes. But is it safe, and why are they doing so?

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...

PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications • ...

More than two years after acquiring Tarus Therapeutics, Portage Biotech is relaunching Tarus’ adenosine receptor antagonists ...